Simplex Trading
DMK

Simplex Trading’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Simplex Trading’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-128
Closed -$1K – 10263
2023
Q1 		$1K Buy
128
+93
+266% +$1.24K ﹤0.01% 8840
2022
Q4 		$0 Sell
35
-42
-55% -$480 ﹤0.01% 10810
2022
Q3 		$1K Buy
+77
New +$1.99K ﹤0.01% 9722
2021
Q2 		– Sell
-171
Closed -$10.4K – 10890
2021
Q1 		$11K Buy
+171
New +$13.3K ﹤0.01% 7860
2019
Q3 		– Sell
-12
Closed -$862 – 8062
2019
Q2 		$1K Buy
+12
New +$1.46K ﹤0.01% 6937
2018
Q4 		– Sell
-426
Closed -$81.7K – 8022
2018
Q3 		$104K Buy
+426
New +$101K ﹤0.01% 4400
2018
Q2 		– Sell
-481
Closed -$129K – 8027
2018
Q1 		$117K Buy
481
+471
+4,710% +$124K 0.01% 1680
2017
Q4 		$3K Sell
10
-354
-97% -$116K ﹤0.01% 5020
2017
Q3 		$133K Buy
364
+234
+180% +$83K 0.01% 1491
2017
Q2 		$47K Buy
+130
New +$38.9K ﹤0.01% 2456
2017
Q1 		– Sell
-204
Closed -$51.5K – 6940
2016
Q4 		$45K Sell
204
-200
-50% -$40.1K ﹤0.01% 2258
2016
Q3 		$96K Buy
+404
New +$84K 0.01% 1560
2016
Q2 		– Sell
-17
Closed -$7.84K – 6612
2016
Q1 		$7K Buy
+17
New +$6.07K ﹤0.01% 3843
2015
Q2 		– Sell
-67
Closed -$20.2K – 6015
2015
Q1 		$18K Buy
+67
New +$28.9K ﹤0.01% 2429

Other funds holding DMK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Simplex Trading's DMK Position: Q2 2023 in Review

Simplex Trading sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q2 2023, closing a stake of 128 shares — an estimated $1K sold.

Simplex Trading first reported a position in DMK in Q1 2015 and held it in 14 quarters. The position peaked at $133K in Q3 2017. 22 funds tracked by Wall St. Rank hold DMK as of Q2 2023.

  • Simplex Trading reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q2 2023 after selling out during the quarter.
  • Simplex Trading sold 128 DMK Pharmaceuticals Corporation Common Stock shares in Q2 2023, an estimated $1K.
  • Simplex Trading first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q1 2015 and held it in 14 quarters.
  • Simplex Trading's DMK Pharmaceuticals Corporation Common Stock position peaked at $133K in Q3 2017.
  • 22 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q2 2023.

Based on Simplex Trading's 13F filing for Q2 2023, filed 4 Aug 2023.